Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 5Phase 1/2 3Phase NA 2

Status

Completed 163Recruiting 59Unknown 47Active not recruiting 19Terminated 17Not yet recruiting 8Withdrawn 7Suspended 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2Genitourinary 1

Conditions

Breast Neoplasms 13Brain Neoplasms 9Prostatic Neoplasms 7Neoplasms 7Head and Neck Neoplasms 6Motor Activity 4Glioma 4Glioblastoma 4Triple Negative Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pain 3Colorectal Neoplasms 3Quality of Life 2Papillomavirus Infections 2Pancreatic Neoplasms 2Obesity 2Multiple Myeloma 2Melanoma 2Lymphoma, Follicular 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Depression 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Cancer Pain 2Biliary Tract Neoplasms 2Behavior 2Weight Loss 1Venous Thromboembolism 1Ureteral Neoplasms 1

Interventions

Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Ketones 1Glucose 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Suspended × Melanoma × Clear all
NCT06391099 2026-05-26

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT04866810 2026-04-27

The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN)

National Institutes of Health Clinical Center (CC)

Phase NA Suspended
24 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡